Offer - Urjas Oil for just ₹ 1
Renvela 400 Mg Tablet is a prescription drug, available for use as Tablet. It is primarily used for the treatment of Increased Phosphate Levels in the Blood. The alternative uses of Renvela 400 Mg Tablet have also been explained below.
The correct dosage of Renvela 400 Mg Tablet depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
While these are the most often observed Renvela 400 Mg Tablet side effects, there are can be others also. These have been listed below. Normally, these side effects of Renvela 400 Mg Tablet are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Renvela 400 Mg Tablet has a Unknown effect for pregnant women and Safe effect on lactating mothers. In addition, Renvela 400 Mg Tablet's effects on the liver, heart and kidney are discussed below in the Renvela 400 Mg Tablet related warnings section.
Renvela 400 Mg Tablet is contraindicated in people with pre-existing medical conditions like Intestinal Obstruction as it can result in adverse effects. Other contraindications of Renvela 400 Mg Tablet have been discussed in the sections ahead.
Additionally, Renvela 400 Mg Tablet may also adversely react with other medicines. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Renvela 400 Mg Tablet is safe while driving, and is is addictive in nature.
Renvela 400 Mg Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Is the use of Renvela 400 Mg Tablet safe for pregnant women?
No research has been done to ascertain the safety of Renvela in pregnant women. If you are pregnant, it is best to ask a doctor to know if you can take it.
Is the use of Renvela 400 Mg Tablet safe during breastfeeding?
Breastfeeding women can safely use Renvela.
What is the effect of Renvela 400 Mg Tablet on the Kidneys?
Renvela may have mild side effects on the kidneys.
What is the effect of Renvela 400 Mg Tablet on the Liver?
In the absence of any scientific study on the side effects of Renvela on the liver, information on safety of Renvela for liver is unavailable.
What is the effect of Renvela 400 Mg Tablet on the Heart?
No research work has been carried out till date on effects of Renvela on heart. So it is not known whether taking Renvela will cause side effects on heart or not.
If you are suffering from any of the following diseases, you should not take Renvela 400 Mg Tablet unless your doctor advises you to do so -
Is this Renvela 400 Mg Tablet habit forming or addictive?
Renvela 400 Mg Tablet does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can operate a vehicle or heavy machinery after taking Renvela 400 Mg Tablet since it does not cause drowsiness.
Is it safe?
Yes, Renvela 400 Mg Tablet is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, Renvela 400 Mg Tablet is not used to treat mental disorders.
Interaction between Food and Renvela 400 Mg Tablet
Due to the absence of research, it is difficult to say how Renvela 400 Mg Tablet and food will interact.
Interaction between Alcohol and Renvela 400 Mg Tablet
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Renvela 400 Mg Tablet.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Renvela (sevelamer carbonate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1134-1135